110 related articles for article (PubMed ID: 3308080)
1. Phase II trial of recombinant beta interferon in advanced colorectal cancer.
Lillis PK; Brown TD; Beougher K; Koeller J; Marcus SG; Von Hoff DD
Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080
[TBL] [Abstract][Full Text] [Related]
2. Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.
Triozzi PL; Kenney P; Young D; Rinehart JJ
Cancer Treat Rep; 1987 Oct; 71(10):983-4. PubMed ID: 3308083
[No Abstract] [Full Text] [Related]
3. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
Figlin RA; Callaghan M; Sarna G
Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
[TBL] [Abstract][Full Text] [Related]
4. Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma.
Ajani JA; Rios AA; Ende K; Abbruzzese JL; Edwards C; Faintuch JS; Saks S; Gutterman JU; Levin B
J Biol Response Mod; 1989 Apr; 8(2):140-6. PubMed ID: 2499663
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of high-dose recombinant leukocyte alpha-2 interferon for metastatic colorectal cancer without previous systemic treatment.
Eggermont AM; Weimar W; Marquet RL; Laméris JD; Jeekel J
Cancer Treat Rep; 1985 Feb; 69(2):185-7. PubMed ID: 3882227
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
Rinehart J; Malspeis L; Young D; Neidhart J
Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
Chaplinski T; Laszlo J; Moore J; Silverman P
Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
[TBL] [Abstract][Full Text] [Related]
8. High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses.
Krown SE; Mintzer D; Cunningham-Rundles S; Niedzwiecki D; Krim M; Einzig AI; Gabrilove JL; Shurgot B; Gessula J
Cancer Treat Rep; 1987 Jan; 71(1):39-45. PubMed ID: 3791267
[TBL] [Abstract][Full Text] [Related]
9. Minimal activity of recombinant clone a interferon in metastatic colon cancer.
Neefe JR; Silgals R; Ayoob M; Schein PS
J Biol Response Mod; 1984 Aug; 3(4):366-70. PubMed ID: 6481401
[TBL] [Abstract][Full Text] [Related]
10. Phase I evaluation of a synthetic mutant of beta-interferon.
Hawkins M; Horning S; Konrad M; Anderson S; Sielaff K; Rosno S; Schiesel J; Davis T; DeMets D; Merigan T
Cancer Res; 1985 Nov; 45(11 Pt 2):5914-20. PubMed ID: 4053062
[TBL] [Abstract][Full Text] [Related]
11. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer.
Cantrell JE; Hart RD; Taylor RF; Harvey JH
Cancer Treat Rep; 1987 Jun; 71(6):615-8. PubMed ID: 3555789
[TBL] [Abstract][Full Text] [Related]
12. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
Figlin RA; deKernion JB; Maldazys J; Sarna G
Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
[TBL] [Abstract][Full Text] [Related]
13. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.
Sarosy GA; Brown TD; Von Hoff DD; Spiegel RJ; Golando JP; Beougher KL; Kuhn JG; Kisner DL
Cancer Res; 1986 Oct; 46(10):5368-71. PubMed ID: 3756887
[TBL] [Abstract][Full Text] [Related]
15. Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
Sarna G; Figlin R; Callaghan M
J Biol Response Mod; 1983; 2(4):343-7. PubMed ID: 6315898
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
[TBL] [Abstract][Full Text] [Related]
17. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
19. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
[TBL] [Abstract][Full Text] [Related]
20. Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma.
Wadler S; Haynes H; Rozenblit A; Hu X; Kaleya R; Wiernik PH
Cancer J Sci Am; 1998; 4(5):331-7. PubMed ID: 9815298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]